Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Algorithm for managing the platelet refractory patient

S J Slichter1

  • 1Puget Sound Blood Center, Seattle, WA 98104-1256, USA.

Journal of Clinical Apheresis
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial.

Vox sanguinis·2016
Same author

Further studies to evaluate methods of leucoreduction to prevent alloimmune platelet refractoriness and induce tolerance in a dog platelet transfusion model.

Vox sanguinis·2016
Same author

Extended storage of autologous apheresis platelets in plasma.

Vox sanguinis·2013
Same author

Platelet transfusion: future directions.

Vox sanguinis·2004
Same author

Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin.

Blood·2001
Same author

Universal WBC reduction.

Transfusion·2000
Same journal

Using Preoperative Therapeutic Plasma Exchange in Lupus Anticoagulant Hypoprothrombinemia Syndrome to Achieve Hemostatic Factor II Activity: A Case Report.

Journal of clinical apheresis·2026
Same journal

Calcium and Other Electrolyte Management in Patients Undergoing Leukocytapheresis Collections: Review and Recommendations From the American Society for Apheresis Clinical Applications Committee.

Journal of clinical apheresis·2026
Same journal

The Role of Therapeutic Apheresis in the Management of Rheumatoid Arthritis A Systematic Review and Meta-Analysis.

Journal of clinical apheresis·2026
Same journal

Thrombocytapheresis as a Bridge Intervention in JAK2-Mutant Myeloproliferative Neoplasm Complicated by Acquired von Willebrand Disease: A Case Report.

Journal of clinical apheresis·2026
Same journal

Plerixafor Plus G-CSF Versus Etoposide Combined With Cyclophosphamide and G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Single Center Observational Propensity Score-Matched Cohort Study.

Journal of clinical apheresis·2026
Same journal

Beyond the Centrifuge: Is FcRn Inhibition Ready to Replace Apheresis in Treatment of Guillain-Barré Syndrome?

Journal of clinical apheresis·2026
See all related articles

Platelet transfusion refractoriness is a significant challenge for thrombocytopenic patients. This study proposes an algorithm to manage these patients, moving from simple to complex interventions for improved platelet transfusion responses.

Area of Science:

  • Hematology
  • Transfusion Medicine

Background:

  • Platelet transfusion refractoriness poses a major clinical challenge for thrombocytopenic patients.
  • Effective management strategies are crucial for patients unresponsive to standard platelet transfusions.

Purpose of the Study:

  • To present a management algorithm for patients experiencing refractoriness to platelet transfusions.
  • To outline a stepwise approach from basic to advanced transfusion strategies.

Main Methods:

  • The proposed algorithm starts with easily implemented changes like ABO-compatible and fresh platelet transfusions.
  • It progresses to selecting HLA-matched platelets for alloimmunized patients.
  • Identifies clinical and drug factors affecting transfusion response in non-alloimmunized patients.

Related Experiment Videos

Main Results:

  • The algorithm provides a structured approach to managing platelet transfusion refractoriness.
  • Factors influencing transfusion response in non-alloimmunized patients have been identified, though causality remains challenging to establish.
  • The approach aims to optimize platelet support for refractory patients.

Conclusions:

  • A systematic algorithm can guide the management of platelet transfusion refractoriness.
  • Further research is needed to definitively link specific factors to poor platelet response in individual patients.
  • Optimizing platelet transfusion strategies is essential for improving outcomes in thrombocytopenic patients.